Clinical Trials - RLYB

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06797375Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy ParticipantsRECRUITINGPHASE12025-04-142026-062026-04
NCT06435845Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a AlloimmunizationACTIVE_NOT_RECRUITINGPHASE22024-11-212027-052027-05